pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,603 catalysts · 5,347 phase readout · 2,315 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 20 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: recall×type: earnings×clear all
type
  • phase readout5,347
  • 8k filing2,315
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT06333925: Using Neurostimulation to Accelerate Change in Misophonia: a Pilot Study

Sponsor: Duke University. Phase: NA. Conditions: Misophonia, Emotion Dysregulation, Sensory Processing Disorder, Auditory Over Responsivity, Anxiety Disorder, Sound Sensitivity

full page →ctgov ↗
›COMPLETEDphase readoutNCT06318325: Growth Process and Development of the Musculoskeletal System in Young Gymnasts

Sponsor: University of Haifa. Phase: . Conditions: Development, Adolescent

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07589725: Mulligan Mobilization in Lateral Elbow Tendinopathy

Sponsor: Istanbul Kent University. Phase: NA. Conditions: Lateral Elbow Tendinopathy (Tennis Elbow)

full page →ctgov ↗
›COMPLETEDphase readoutNCT04334525: Promoting Healthier Eating Among Children in Restaurants

Sponsor: State University of New York at Buffalo. Phase: NA. Conditions: Diet, Healthy

full page →ctgov ↗
›COMPLETEDphase readoutNCT04187976: Eosinophils Endotypes in Chronic Airway Inflammatory Diseases

Sponsor: University Hospital, Lille. Phase: . Conditions: Eosinophilic Asthma, Chronic Sinusitis, Eosinophilic Rhinitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07305376: Older Adults' Attitudes Towards Stopping Aspirin

Sponsor: University of Michigan. Phase: NA. Conditions: Medication Overuse

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07550335: Group Reading and Oral Exercise Program for Older Adults

Sponsor: Mackay Memorial Hospital. Phase: NA. Conditions: Oral Frailty, Depression, Sarcopenia, Physical Function Decline

full page →ctgov ↗
›RECRUITINGphase readoutNCT07170176: Effects of PFO Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine

Sponsor: First Affiliated Hospital Xi'an Jiaotong University. Phase: NA. Conditions: Migraine Disorders, Patent Foramen Ovale, Right-to-Left Shunt, Cardiac

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07515976: Mapping of Genomic Structural Variations in Major Birth Defects

Sponsor: Peking Union Medical College Hospital. Phase: . Conditions: Prenatal Diagnosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04016376: Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE4. Conditions: Breast Cancer, Breast Cancer Female

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01708408: The MURDOCK Study Registry and Biorepository Horizon 1.5

Sponsor: Duke University. Phase: . Conditions: Chronic Disease, Healthy Volunteers

full page →ctgov ↗
›COMPLETEDphase readoutNCT04579276: Different Approaches to Thoracic Paravertebral Block

Sponsor: Assistance Publique Hopitaux De Marseille. Phase: NA. Conditions: Thoracotomy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07136545: A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)

Sponsor: Taipei Veterans General Hospital, Taiwan. Phase: PHASE1. Conditions: HNSCC

full page →ctgov ↗
›RECRUITINGphase readoutNCT06944795: SWIR Otoscopy Study

Sponsor: Stanford University. Phase: NA. Conditions: Otitis Media, Otitis Media Chronic, Otitis Media Effusion

full page →ctgov ↗
›COMPLETEDphase readoutNCT03624595: Low-dose Dexmedetomidine and Postoperative Delirium After Cardiac Surgery

Sponsor: Dong-Xin Wang. Phase: NA. Conditions: Cardiac Surgery, Cardiopulmonary Bypass, Dexmedetomidine, Delirium, Survival

full page →ctgov ↗
›COMPLETEDphase readoutNCT02433795: Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)

Sponsor: Seoul National University Hospital. Phase: PHASE2. Conditions: Marginal Zone B-cell Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT04408495: Intraoperative Mechanical Ventilation and Postoperative Pulmonary Complications After On-pump Cardiac Surgery in High-risk Patients

Sponsor: Rennes University Hospital. Phase: NA. Conditions: Postoperative Pulmonary Complications

full page →ctgov ↗
›TERMINATEDphase readoutNCT04990895: A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys

Sponsor: AHS Cancer Control Alberta. Phase: NA. Conditions: Colorectal Cancer, Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07321639: Ultrasound-Guided Regional Blocks for Postoperative Analgesia After Laparoscopic Cholecystectomy

Sponsor: Istanbul Medipol University Hospital. Phase: NA. Conditions: Laparoscopic Cholecystectomy, Acute Pain, Pain Management, Plane Blocks

full page →ctgov ↗
›RECRUITINGphase readoutNCT07308639: DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.

Sponsor: Bayer. Phase: . Conditions: Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06639477: Assessing Improvements in Mood and Sleep Trial

Sponsor: University of Pittsburgh. Phase: NA. Conditions: Depression, Suicidality, Sleep

full page →ctgov ↗
›COMPLETEDphase readoutNCT07011277: Gait Characteristics of Women With Breast Cancer-Related Lymphedema

Sponsor: Gazi University. Phase: . Conditions: Breast Cancer Related Lymphedema

full page →ctgov ↗
›RECRUITINGphase readoutNCT06979375: A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy

Sponsor: Novo Nordisk A/S. Phase: PHASE2. Conditions: Heart Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT03403257: Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)

Sponsor: University of Michigan. Phase: . Conditions: Dementia, Dementia Alzheimers, Dementia, Vascular, Dementia, Mixed

full page →ctgov ↗
›COMPLETEDphase readoutNCT00339157: Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: PHASE2. Conditions: Systemic-Onset Juvenile Idiopathic Arthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06124157: A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: B Acute Lymphoblastic Leukemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07619157: A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus

Sponsor: Ono Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Type2 Diabetes Mellitus, Chronic Kidney Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07400601: A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at Zhongshan Hospital

Sponsor: Shanghai Zhongshan Hospital. Phase: . Conditions: Acute Myocardial Infarction (AMI)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06975501: Community-Empowerment and Environmental Enrichment-based Co-management (CEEEC) Model and Mechanisms for Improving Health of Older Stroke Patients With Multimorbidity

Sponsor: Duke Kunshan University. Phase: NA. Conditions: Hypertension, Type 2 Diabetes Mellitus (T2DM), Multimorbidity, Stroke

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07443501: Reducing Post-Letermovir CMV Infection: Efficacy of an Immune-Reconstitution-Based Scoring System to Guide Prophylaxis Duration

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: . Conditions: CMV Infection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07600801: LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B

Sponsor: Massachusetts General Hospital. Phase: . Conditions: Family History of Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07058012: A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

Sponsor: NSABP Foundation Inc. Phase: PHASE2. Conditions: Colo-rectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07334912: AEF0217 in Participants With Down Syndrome

Sponsor: Aelis Farma. Phase: PHASE2. Conditions: Down Syndrome (Trisomy 21)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05388812: Together in Recovery With Veterans Through Employment

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Veterans With Opioid Use Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07498881: LasaiON is an Evidence-informed, Multimodal Self-regulation Program Designed to Reduce Emotional Distress and Strengthen Stress-regulation Skills by Combining Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) With Breathing Supported by Heart-rate Variability Biofeedback (HRV-B; emWave).

Sponsor: University of the Basque Country (UPV/EHU). Phase: NA. Conditions: Adult

full page →ctgov ↗
›COMPLETEDphase readoutNCT00448981: Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial

Sponsor: Centers for Disease Control and Prevention. Phase: NA. Conditions: Respiratory Tract Infections, Common Cold

full page →ctgov ↗
›COMPLETEDphase readoutNCT06961981: Remote Vinyasa Yoga Program for Heart Health

Sponsor: West Virginia University. Phase: NA. Conditions: Hypertension, Cardiovascular Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT06802081: TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation

Sponsor: The Cleveland Clinic. Phase: PHASE2. Conditions: Atrial Fibrillation, Obesity

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05430230: Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis

Sponsor: Northwestern University. Phase: PHASE4. Conditions: Osteoarthritis, Knee

full page →ctgov ↗
›RECRUITINGphase readoutNCT07568730: A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis

Sponsor: TearSolutions, Inc.. Phase: PHASE2. Conditions: Neurotrophic Keratitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07698028: ExMI vs. Biofeedback PFMT for Post-Prostatectomy Incontinence

Sponsor: Tanta University. Phase: NA. Conditions: Post-Prostatectomy Urinary Incontinence, Benign Prostatic Hyperplasia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07447128: Prospective Analysis of Arteriovenous Access (AVA) Use in Continuous Renal Replacement Therapy: A Feasibility Project

Sponsor: East Carolina University. Phase: NA. Conditions: Continuous Renal Replacement Therapy (CRRT), End Stage Kidney Disease (ESRD)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03847428: Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment

Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Hepatocellular Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07294365: A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)

Sponsor: Dizal Pharmaceuticals. Phase: PHASE2. Conditions: Immune Thrombocytopenia (ITP)

full page →ctgov ↗
›RECRUITINGphase readoutNCT03304665: Recruitment and Characterization of Healthy Research Volunteers for NIMH Intramural Studies

Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Healthy Volunteer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06906107: Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief

Sponsor: Baylor University. Phase: NA. Conditions: Neck Pain Musculoskeletal, Neck Pain Treatment, Cervicalgia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07498907: Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma

Sponsor: Peking University First Hospital. Phase: PHASE2. Conditions: Upper Tract Urothelial Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05987592: BE WELL With Migraine: Brain Education and WELLness With Migraine

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Migraine

full page →ctgov ↗
›WITHDRAWNphase readoutNCT03297892: Health Status of the Patients Followed for a Disease of Cushing in the Region Large-West of 1990 to 2015

Sponsor: University Hospital, Brest. Phase: . Conditions: Cushing Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06915792: PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy

Sponsor: University of California, Los Angeles. Phase: PHASE4. Conditions: Postpartum Hypertension (PPHT)

full page →ctgov ↗
← prev
page 111 of 113
next →